SCHEMBL27345973

SCHEMBL27345973

NC(=O)NSc1ccc(Cl)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 2/20 0.50
CYP2C9 P11712 3/20 0.46
CYP2C19 P33261 3/20 0.46
HSD17B10 Q99714 2/20 0.42
MAPT P10636 5/20 0.41
ALDH1A1 P00352 4/20 0.41
LMNA P02545 2/20 0.41
KDM4E B2RXH2 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
CYP1A2 P05177 2/20 0.41
TSHR P16473 3/20 0.40
HPGD P15428 2/20 0.40
ALOX15 P16050 2/20 0.40
TEAD1 P28347 1/20 0.40
YAP1 P46937 1/20 0.40
TEAD4 Q15561 1/20 0.40
TEAD2 Q15562 1/20 0.40
GAA P10253 1/20 0.40
HTT P42858 3/20 0.39
PKM P14618 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19345940 0.81 CYP3A4 (0.42) NPC1CYP2C9CYP2C19HSD17B10MAPT
SCHEMBL6916759 0.81 CYP2C9 (0.48) NPC1CYP2C9CYP2C19HSD17B10MAPT
SCHEMBL158241 0.78 SIRT1 (0.42) NPC1CYP2C19HSD17B10MAPTALDH1A1
SCHEMBL11409862 0.76 ALDH1A1 (0.53) NPC1CYP2C9CYP2C19HSD17B10MAPT
SCHEMBL4558245 0.76 NPC1 (0.41) NPC1MAPTLMNAKDM4ETSHR
SCHEMBL29666482 0.76 MEN1 (0.43) NPC1CYP2C9CYP2C19HSD17B10MAPT
SCHEMBL28544441 0.76 MEN1 (0.43) NPC1CYP2C9CYP2C19HSD17B10MAPT
SCHEMBL24325340 0.75 ALDH1A1 (0.54) NPC1MAPTALDH1A1LMNAL3MBTL1
SCHEMBL22688977 0.74 ALDH1A1 (0.44) NPC1MAPTALDH1A1LMNAKDM4E
SCHEMBL6465460 0.73 TSHR (0.52) MAPTALDH1A1LMNATSHRHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101687816-A Triaminopyrimidine derivatives as the CDC25 inhibitors of phosphatases IPSEN PHARMA SAS 2010-03-31 CN claimed
CN-103442566-B The compound of Therapeutic cancer GTX, INC. (US) 2015-12-09 CN disclosed
CN-104610222-A Process for preparing episulfide compounds ASAHI KASEI CHEMICALS CORP 2015-05-13 CN disclosed
CN-103476764-A Process for producing episulfide compound ASAHI KASEI CHEMICALS CORP (JP) 2013-12-25 CN disclosed
CN-1926121-B Thiazole derivatives and uses thereof MERCK SERONO SA 2012-06-13 CN disclosed
CN-102285936-A 4-thiazolidone carboxylic acid derivative and preparation method and application thereof 2011-12-21 CN disclosed
CN-101875961-A Be used to prevent and treat associated conditions and as the diaryl and the aryl heteroaryl urea derivatives of 5-HT2A serotonin receptor modulator ARENA PHARM INC 2010-11-03 CN disclosed
CN-101871931-A Be used to prevent and treat associated conditions and as the diaryl and the aryl heteroaryl urea derivatives of 5-HT2A serotonin receptor modulator ARENA PHARM INC 2010-10-27 CN disclosed
CN-101687816-A Triaminopyrimidine derivatives as the CDC25 inhibitors of phosphatases IPSEN PHARMA SAS 2010-03-31 CN disclosed
CN-101624371-A 4-carbostyril and 4H-1,4-benzothiazine derivatives and preparation method and application thereof UNIV CHINA PHARMA 2010-01-13 CN disclosed
CN-1926121-A Thiazole derivatives and uses thereof APPLIED RESEARCH SYSTEMS (AN) 2007-03-07 CN disclosed
CN-1826322-A Diaryl and arylheteroaryl urea derivatives as modulators of the 5-HT 2A serotonin receptor for the prevention and treatment of related disorders ARENA PHARM INC (US) 2006-08-30 CN disclosed
CN-1035253-C Pyranyl cyanoguanidine derivatives SQUIBB & SONS INC (US) 1997-06-25 CN disclosed
CN-1064272-A PYRANYL CYANOGUANIDINE DERIVATIVES SQUIBB & SONS INC (US) 1992-09-09 CN disclosed